Whole-Brain N-Acetylaspartate Concentration Is Preserved during Mild Hypercapnia Challenge

REFERENCES

1. 1.↵
   2. Oz G,
   3. Alger JR,
   4. Barker PB, et al

   ; MRS Consensus Group. Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014;270:658–79 doi:10.1148/radiol.13130531 pmid:24568703

   CrossRefPubMed
2. 2.↵
   2. Mountford CE,
   3. Stanwell P,
   4. Lin A, et al

   . Neurospectroscopy: the past, present and future. Chem Rev 2010;110:3060–86 doi:10.1021/cr900250y pmid:20387805

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Moffett JR,
   3. Ross B,
   4. Arun P, et al

   . N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007;81:89–131 doi:10.1016/j.pneurobio.2006.12.003 pmid:17275978

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Baslow MH

   . N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 2003;28:941–53 doi:10.1023/A:1023250721185 pmid:12718449

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Taylor DL,
   3. Davies SE,
   4. Obrenovitch TP, et al

   . Extracellular N-acetylaspartate in the rat brain: in vivo determination of basal levels and changes evoked by high K+. J Neurochem 1994;62:2349–55 pmid:8189239

   PubMedWeb of Science
6. 6.↵
   2. Benarroch EE

   . N-acetylaspartate and N-acetylaspartylglutamate: neurobiology and clinical significance. Neurology 2008;70:1353–57 doi:10.1212/01.wnl.0000311267.63292.6c pmid:18413589

   FREE Full Text
7. 7.↵
   2. Baslow MH,
   3. Guilfoyle DN

   . Canavan disease, a rare early-onset human spongiform leukodystrophy: insights into its genesis and possible clinical interventions. Biochimie 2013;95:946–56 doi:10.1016/j.biochi.2012.10.023 pmid:23151389

   CrossRefPubMed
8. 8.↵
   2. Choi IY,
   3. Gruetter R

   . Dynamic or inert metabolism? Turnover of N-acetyl aspartate and glutathione from D-[1–13C]glucose in the rat brain in vivo. J Neurochem 2004;91:778–87 doi:10.1111/j.1471-4159.2004.02716.x pmid:15525331

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Caglar E,
   3. Sabuncuoğlu H,
   4. Keskin T, et al

   . In vivo human brain biochemistry after aerobic exercise: preliminary report on functional magnetic resonance spectroscopy. Surg Neurol 2005;64 (suppl 2):S53–56; discussion S56–67 pmid:16256843

   CrossRefPubMed
10. 10.↵
    2. Hagino H,
    3. Suzuki M,
    4. Mori K, et al

    . Proton magnetic resonance spectroscopy of the inferior frontal gyrus and thalamus and its relationship to verbal learning task performance in patients with schizophrenia: a preliminary report. Psychiatry Clin Neurosci 2002;56:499–507 doi:10.1046/j.1440-1819.2002.01045.x pmid:12193238

    CrossRefPubMed
11. 11.↵
    2. Dager SR,
    3. Layton ME,
    4. Strauss W, et al

    . Human brain metabolic response to caffeine and the effects of tolerance. Am J Psychiatry 1999;156:229–37 pmid:9989559

    PubMedWeb of Science
12. 12.↵
    2. Liu H,
    3. Zheng W,
    4. Yan G, et al

    . Acute ethanol-induced changes in edema and metabolite concentrations in rat brain. Biomed Res Int 2014;2014:351903 doi:10.1155/2014/351903 pmid:24783201

    CrossRefPubMed
13. 13.↵
    2. Rao R,
    3. Ennis K,
    4. Long JD, et al

    . Neurochemical changes in the developing rat hippocampus during prolonged hypoglycemia. J Neurochem 2010;114:728–38 doi:10.1111/j.1471-4159.2010.06797.x pmid:20477939

    CrossRefPubMed
14. 14.↵
    2. Rigotti DJ,
    3. Inglese M,
    4. Gonen O

    . Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders. AJNR Am J Neuroradiol 2007;28:1843–9 doi:10.3174/ajnr.A0774 pmid:17921226

    Abstract/FREE Full Text
15. 15.↵
    2. Marshall O,
    3. Lu H,
    4. Brisset JC, et al

    . Impaired cerebrovascular reactivity in multiple sclerosis. JAMA Neurol 2014;71:1275–81 doi:10.1001/jamaneurol.2014.1668 pmid:25133874

    CrossRefPubMed
16. 16.↵
    2. Pollock JM,
    3. Deibler AR,
    4. Whitlow CT, et al

    . Hypercapnia-induced cerebral hyperperfusion: an underrecognized clinical entity. AJNR Am J Neuroradiol 2009;30:378–85 doi:10.3174/ajnr.A1316 pmid:18854443

    Abstract/FREE Full Text
17. 17.↵
    2. Bates TE,
    3. Strangward M,
    4. Keelan J, et al

    . Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 1996;7:1397–400 doi:10.1097/00001756-199605310-00014 pmid:8856684

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Gonen O,
    3. Viswanathan AK,
    4. Catalaa I, et al

    . Total brain N-acetylaspartate concentration in normal, age-grouped females: quantitation with non-echo proton NMR spectroscopy. Magn Reson Med 1998;40:684–89 doi:10.1002/mrm.1910400506 pmid:9797150

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Soher BJ,
    3. Wu WE,
    4. Tal A, et al

    . Automated whole-brain N-acetylaspartate proton MRS quantification. NMR Biomed 2014;27:1275–84 doi:10.1002/nbm.3185 pmid:25196714

    CrossRefPubMed
20. 20.↵
    2. Hu J,
    3. Javaid T,
    4. Arias-Mendoza F, et al

    . A fast, reliable, automatic shimming procedure using 1H chemical-shift-imaging spectroscopy. J Magn Reson B 1995;108:213–19 doi:10.1006/jmrb.1995.1126 pmid:7670755

    CrossRefPubMed
21. 21.↵
    2. Lu H,
    3. Ge Y

    . Quantitative evaluation of oxygenation in venous vessels using T2-relaxation-under-spin-tagging MRI. Magn Reson Med 2008;60:357–63 doi:10.1002/mrm.21627 pmid:18666116

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Wu WC,
    3. Fernández-Seara M,
    4. Detre JA, et al

    . A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med 2007;58:1020–27 doi:10.1002/mrm.21403 pmid:17969096

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Soher BJ,
    3. Semanchuk P,
    4. Todd D, et al

    . Vespa: Integrated applications for RF pulse design, spectral simulation and MRS data analysis. In: Proceedings of the Annual Meeting of the International Society for Magnetic Resonance in Medicine, Montreal, Quebec, Canada. May 6–13, 2011:1410
24. 24.↵
    2. Young K,
    3. Soher BJ,
    4. Maudsley AA

    . Automated spectral analysis II: application of wavelet shrinkage for characterization of non-parameterized signals. Magn Reson Med 1998;40:816–21 doi:10.1002/mrm.1910400606 pmid:9840825

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Soher BJ,
    3. Young K,
    4. Govindaraju V, et al

    . Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998;40:822–31 doi:10.1002/mrm.1910400607 pmid:9840826

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Aslan S,
    3. Xu F,
    4. Wang PL, et al

    . Estimation of labeling efficiency in pseudocontinuous arterial spin labeling. Magn Reson Med 2010;63:765–71 doi:10.1002/mrm.22245 pmid:20187183

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Lu H,
    3. Clingman C,
    4. Golay X, et al

    . Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med 2004;52:679–82 doi:10.1002/mrm.20178 pmid:15334591

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Kety SS,
    3. Schmidt CF

    . The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest 1948;27:476–83 doi:10.1172/JCI101994 pmid:16695568

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Yezhuvath US,
    3. Uh J,
    4. Cheng Y, et al

    . Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease. Neurobiol Aging 2012;33:75–82 doi:10.1016/j.neurobiolaging.2010.02.005 pmid:20359779

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Donahue MJ,
    3. Strother MK,
    4. Hendrikse J

    . Novel MRI approaches for assessing cerebral hemodynamics in ischemic cerebrovascular disease. Stroke 2012;43:903–15 doi:10.1161/STROKEAHA.111.635995 pmid:22343644

    Abstract/FREE Full Text
31. 31.↵
    2. Mark CI,
    3. Slessarev M,
    4. Ito S, et al

    . Precise control of end-tidal carbon dioxide and oxygen improves BOLD and ASL cerebrovascular reactivity measures. Magn Reson Med 2010;64:749–56 doi:10.1002/mrm.22405 pmid:20648687

    CrossRefPubMed
32. 32.↵
    2. Wang X,
    3. Wu J,
    4. Li L, et al

    . Hypercapnic acidosis activates KATP channels in vascular smooth muscles. Circ Res 2003;92:1225–32 doi:10.1161/01.RES.0000075601.95738.6D pmid:12738754

    Abstract/FREE Full Text
33. 33.↵
    2. Sicard KM,
    3. Duong TQ

    . Effects of hypoxia, hyperoxia, and hypercapnia on baseline and stimulus-evoked BOLD, CBF, and CMRO2 in spontaneously breathing animals. Neuroimage 2005;25:850–58 doi:10.1016/j.neuroimage.2004.12.010 pmid:15808985

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Xu F,
    3. Uh J,
    4. Brier MR, et al

    . The influence of carbon dioxide on brain activity and metabolism in conscious humans. J Cereb Blood Flow Metab 2011;31:58–67 doi:10.1038/jcbfm.2010.153 pmid:20842164

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Jones M,
    3. Berwick J,
    4. Hewson-Stoate N, et al

    . The effect of hypercapnia on the neural and hemodynamic responses to somatosensory stimulation. Neuroimage 2005;27:609–23 doi:10.1016/j.neuroimage.2005.04.036 pmid:15978844

    CrossRefPubMedWeb of Science
36. 36.↵
    2. Douglas RM,
    3. Ryu J,
    4. Kanaan A, et al

    . Neuronal death during combined intermittent hypoxia/hypercapnia is due to mitochondrial dysfunction. Am J Physiol Cell Physiol 2010;298:C1594–602 doi:10.1152/ajpcell.00298.2009 pmid:20357179

    Abstract/FREE Full Text
37. 37.↵
    2. Khacho M,
    3. Tarabay M,
    4. Patten D, et al

    . Acidosis overrides oxygen deprivation to maintain mitochondrial function and cell survival. Nat Commun 2014;5:3550 pmid:24686499

    PubMed
38. 38.↵
    2. Barker PB,
    3. Gillard JH,
    4. van Zijl PC, et al

    . Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 1994;192:723–32 doi:10.1148/radiology.192.3.8058940 pmid:8058940

    CrossRefPubMedWeb of Science